Caribou Biosciences, Inc. (CRBU) Misses Q1 EPS by 6c

Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q1 EPS of ($0.46), $0.06 worse than the analyst estimate of ($0.40). Revenue for the quarter came in at $2.43 million versus the consensus estimate of $2.9 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Creatd files Form S-1 and reports Q1 2026 financial results
• Ennis (EBF) Reports In-Line Q1 EPS